Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.770
-0.010 (-0.56%)
Jul 19, 2024, 4:30 PM EDT - Market closed
Biodesix Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Biodesix stock have an average target of 3.15, with a low estimate of 2.80 and a high estimate of 3.50. The average target predicts an increase of 77.97% from the current stock price of 1.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2024.
Analyst Ratings
The average analyst rating for Biodesix stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates $2.8 | Strong Buy | Initiates | $2.8 | +58.19% | May 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +97.74% | Mar 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +97.74% | Dec 7, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +182.49% | May 12, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 20, 2022 |
Financial Forecast
Revenue This Year
68.11M
from 49.09M
Increased by 38.75%
Revenue Next Year
84.44M
from 68.11M
Increased by 23.98%
EPS This Year
-0.37
from -0.64
EPS Next Year
-0.27
from -0.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 72.0M | 87.6M | 106.5M |
| Avg | 68.1M | 84.4M | 102.8M |
| Low | 64.2M | 79.8M | 98.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 46.7% | 28.6% | 26.1% |
| Avg | 38.7% | 24.0% | 21.7% |
| Low | 30.8% | 17.2% | 16.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.36 | -0.23 | -0.15 |
| Avg | -0.37 | -0.27 | -0.17 |
| Low | -0.37 | -0.31 | -0.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.